Showing results (21-30 of 78) with videos related to
Sort By:
Pageof 8
American Journal of Clinical Pathology|August 10, 2004
Malignant melanoma 2003: predisposition, diagnosis, prognosis, and stagingJ Andrew Carlson, Andrzej Slominski, Gerald P Linette, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 11, 2012
Amino-terminal extended peptide single-chain trimers are potent synthetic agonists for memory human CD8+ T cellsBeatriz M Carreno, Michelle Becker-Hapak, Megan Chan, et al.Archives of Dermatology|June 12, 2002
Hypopigmentation associated with an adenovirus-mediated gp100/MART-1-transduced dendritic cell vaccine for metastatic melanomaHensin Tsao, Peri Millman, Gerald P Linette, et al.Genome Medicine|January 31, 2016
pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigensJasreet Hundal, Beatriz M Carreno, Allegra A Petti, et al.Journal of Cutaneous Pathology|March 20, 2014
Histopathologic characteristics of therapy-associated cutaneous neoplasms with vemurafenib, a selective BRAF kinase inhibitor, used in the treatment of melanomaKari E Sufficool, Donna M Hepper, Gerald P Linette, et al.AJR. American Journal of Roentgenology|December 21, 2007
Hepatic arterial chemoembolization for management of metastatic melanomaKarun V Sharma, Jennifer E Gould, J William Harbour, et al.Advances in Anatomic Pathology|June 29, 2004
PharmacogenomicsJeffrey S Ross, David P Schenkein, Oscar Kashala, et al.Molecular & Cellular Proteomics : MCP|February 6, 2004
Targeted therapy in breast cancer: the HER-2/neu gene and proteinJeffrey S Ross, Jonathan A Fletcher, Kenneth J Bloom, et al.Expert Review of Molecular Diagnostics|September 27, 2003
Breast cancer biomarkers and molecular medicineJeffrey S Ross, Gerald P Linette, James Stec, et al.Expert Review of Molecular Diagnostics|March 6, 2004
Breast cancer biomarkers and molecular medicine: part IIJeffrey S Ross, Gerald P Linette, James Stec, et al.Pageof 8